The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells
Open accessAbstract
The Ah receptor (AhR), a bHLH/PAS transcription factor, mediates dioxin toxicity in the immune system, skin, testis and liver. Toxic phenomena are associated with altered cell proliferation or differentiation, but signaling pathways of AhR in cell cycle regulation are poorly understood. Here we show that AhR induces the p27(Kip1) cyclin/cdk inhibitor by altering Kip1 transcription in a direct mode without the need for ongoing protein synthesis or cell proliferation. This is the first example of Kip1 being a direct transcriptional target of a toxic agent that affects cell proliferation. Kip1 causes dioxin-induced suppression of 5L hepatoma cell proliferation because Kip1 antisense-expressing cells are resistant to dioxins. Kip1 is also induced by dioxins in cultures of fetal thymus glands concomitant with inhibition of proliferation and severe reduction of thymocyte recovery. Kip1 expression is likely to mediate these effects as thymic glands of Kip1-deficient mice (Kip1(Delta51)) are largely, though not completely, resistant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,158
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Self-citationMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Pagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
Heim, R., Cubitt, A. B., & Tsien, R. Y. (1995) · Nature · doi:10.1038/373663b0 · Cited by 1,782
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Self-citationRadiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1×
“Yet, p21-deficient cells are only partially impaired in their capacity to arrest proliferation on DNA damage (Brugarolas et al. 1995; Deng et al. 1995) presumably because of alternate pathways that allow even p21-deficient cells to inhibit proliferation on damage.”
BackgroundD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Kociba, R. J., Keyes, D. G., Beyer, J. E., Carreon, R. M., Wade, C. E., Dittenber, D. A., Kalnins, R. P., Frauson, L. E., Park, C. N., Barnard, S. D., et al. (1978) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(78)90075-3 · Cited by 1,057
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
Luciferase reporter gene vectors for analysis of promoters and enhancers.
Nordeen, S. K. (1988) · PubMed · Cited by 994
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899
Translational Control of p27 Kip1 Accumulation During the Cell Cycle
Hengst, L., & Reed, S. I. (1996) · Science · doi:10.1126/science.271.5257.1861 · Cited by 846
Fernandez-Salguero, P. M., Hilbert, D. M., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1996) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1996.0210 · Cited by 836
Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor.
Burbach, K. M., Poland, A., & Bradfield, C. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8185 · Cited by 831
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Migliaccio, A., Piccolo, D., Castoria, G., Di Domenico, M., Bilancio, A., Lombardi, M., Gong, W., Beato, M., & Auricchio, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.2008 · Cited by 626
Identification of a novel mechanism of regulation of Ah (dioxin) receptor function
Mimura, J., Ema, M., Sogawa, K., & Fujii-Kuriyama, Y. (1999) · Genes & Development · doi:10.1101/gad.13.1.20 · Cited by 585
NEBERT, D. W., PUGA, A., & VASILIOU, V. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35928.x · Cited by 423
cDNA cloning and structure of mouse putative Ah receptor
Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., & Fujii-Kuriyama, Y. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91185-s · Cited by 403
DNA Binding Specificities and Pairing Rules of the Ah Receptor, ARNT, and SIM Proteins
Swanson, H. I., Chan, W. K., & Bradfield, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26292 · Cited by 391
The retinoblastoma protein pathway and the restriction point
Bartek, J., Bartkova, J., & Lukas, J. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80081-0 · Cited by 390
Transcriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Pitot, H. C., Goldsworthy, T. L., Campbell, H. A., & Poland, A. (1980) · PubMed · Cited by 371
Control of cell lineage-specific development and transcription by bHLH-PAS proteins
Crews, S. T. (1998) · Genes & Development · doi:10.1101/gad.12.5.607 · Cited by 347
Hoffman, E. S., Passoni, L., Crompton, T., Leu, T. M., Schatz, D. G., Koff, A., Owen, M. J., & Hayday, A. C. (1996) · Genes & Development · doi:10.1101/gad.10.8.948 · Cited by 339
Self-citationTargets for Dioxin: Genes for Plasminogen Activator Inhibitor-2 and Interleukin-1β
Sutter, T. R., Guzman, K., Dold, K. M., & Greenlee, W. F. (1991) · Science · doi:10.1126/science.1925598 · Cited by 337
Cyclin dependent kinase regulation
Lees, E. (1995) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(95)80060-3 · Cited by 285
A Direct Interaction between the Aryl Hydrocarbon Receptor and Retinoblastoma Protein
Ge, N.-L., & Elferink, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22708 · Cited by 258
Rapamycin Resistance Tied to Defective Regulation of p27 Kip1
Luo, Y., Marx, S. O., Kiyokawa, H., Koff, A., Massagué, J., & Marks, A. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6744 · Cited by 210
Self-citationRegulation of thymocyte development from immature progenitors
Zúñiga-Pflücker, J. C., & Lenardo, M. J. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80060-4 · Cited by 177
Weiß, C., Kolluri, S. K., Kiefer, F., & Göttlicher, M. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0214 · Cited by 170
Self-citationCarcinogenicity of TCDD: Experimental, Mechanistic, and Epidemiologic Evidence
Huff, J., Lucier, G., & Tritscher, A. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.002015 · Cited by 169
ahr null alleles: distinctive or different?
Lahvis, G. P., & Bradfield, C. A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00134-8 · Cited by 152
Staples, J. E., Murante, F. G., Fiore, N. C., Gasiewicz, T. A., & Silverstone, A. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.3844 · Cited by 141
A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells
Coats, S., Whyte, P., Fero, M. L., Lacy, S. E., Chung, G., Randel, E., Firpo, E. J., & Roberts, J. M. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80086-4 · Cited by 118
Cancer prognostics: Past, present and p27
Steeg, P. S., & Abrams, J. S. (1997) · Nature Medicine · doi:10.1038/nm0297-152 · Cited by 113
Evidence for a second pathway in the action mechanism of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)
Enan, E. E., & Matsumura, F. (1995) · Biochemical Pharmacology · doi:10.1016/s0006-2952(94)00430-7 · Cited by 93
DNA Binding by the Heterodimeric Ah Receptor
Dong, L., Ma, Q., & Whitlock, J. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.7942 · Cited by 91
Poellinger, L., Göttlicher, M., & Gustafsson, J.-Α. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90076-i · Cited by 85
Lai, Z., Hundeiker, C., Gleichmann, E., & Esser, C. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.30 · Cited by 70
Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1
Kwon, T. K., Nagel, J. E., Buchholz, M. A., & Nordin, A. A. (1996) · Gene · doi:10.1016/s0378-1119(96)00416-7 · Cited by 61
Common threads in eukaryotic circadian systems
Dunlap, J. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80109-3 · Cited by 52
2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes
Hushka, D. R., & Greenlee, W. F. (1995) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(95)00135-2 · Cited by 49
Bauman, J. W., Goldsworthy, T. L., Dunn, C. S., & Fox, T. R. (1995) · Cell Proliferation · doi:10.1111/j.1365-2184.1995.tb00084.x · Cited by 45
The CDK inhibitor, p27Kip1, is required for IL-4 regulation of astrocyte proliferation
Liu, J., Flanagan, W. M., Drazba, J. A., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.812 · Cited by 25
Carboxyl-terminal Domain of p27Kip1 Activates CDC2
Üren, A., Jakus, J., de Mora, J. F., Yeudall, W. A., Santos, E., Gutkind, J. S., & Heidaran, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21669 · Cited by 20
Cited by
Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., & Dalton, T. P. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00310-x · Cited by 1,004
Oxidative pathways of chemical toxicity and oxidative stress biomarkers in marine organisms
Regoli, F., & Giuliani, M. E. (2014) · Marine Environmental Research · doi:10.1016/j.marenvres.2013.07.006 · Cited by 982
The aryl hydrocarbon receptor: multitasking in the immune system
Stockinger, B., Meglio, P. D., Gialitakis, M., & Duarte, J. H. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120245 · Cited by 909
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., & Zhao, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr218 · Cited by 748
Metadata
- Authors
- Kolluri, S. K., Weiss, C., Koff, A., & Gottlicher, M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1999-07-01
- Volume
- 13
- Issue
- 13
- Pages
- 1742-1753
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2105900029
- Cited by
- 364
- References
- 57
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.